Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Front Pediatr ; 12: 1374448, 2024.
Article in English | MEDLINE | ID: mdl-38586155

ABSTRACT

Acute generalized exanthematous pustulosis (AGEP) is an uncommon eruption characterized by sterile pustules on an erythematous background, which is usually associated with drugs. AGEP is described as a self-limiting disease with favorable prognosis. We reported a case of Kawasaki Disease (KD) following AGEP. A 3-year-old male, who was admitted with pustules and five days of fever at our hospital, was diagnosed with AGEP. Despite the skin lesions and fever improving drastically after prednisolone therapy, the fever recurred on hospitalization day 5. The following symptoms suggestive of KD also appeared: bulbar conjunctival hyperemia, cervical lymphadenopathy, erythema of the lips, eruption on his trunk, and erythema and edema of the hands and feet. He was diagnosed with KD and treated with intravenous immunoglobulin. He was discharged on the thirteenth day of hospitalization without cardiac complications. Drug-induced lymphocyte stimulation test revealed carbocysteine as the suspected cause of AGEP, which consequently triggered KD. Because a mucosal lesion is uncommon in AGEP, bulbar conjunctival hyperemia suggested that KD sequentially occurred after AGEP. Since AGEP is benign and self-limited in most cases, it is necessary to differentiate other diseases, including KD, when recurrent fever or rash occurs in the course of AGEP.

2.
Front Pediatr ; 8: 6, 2020.
Article in English | MEDLINE | ID: mdl-32047731

ABSTRACT

Background: Although an etiology of Kawasaki disease (KD) is unknown, an aberrant innate immune system in predisposed individuals has been proposed to play a key role in the development of KD vasculitis. Various etiological pathogens have been proposed as the trigger of KD and a scaled injury preceding symptom onset has been reported as one of them. Here, we report a 17-month-old Japanese female who was hospitalized due to high fever lasting for 4 days with infection ruled out as a cause. On admission, she displayed severe sunburn all over her body following a prolonged period of outdoor play 5 days ago. On the 5 day of illness, she developed complete KD. Serum levels of high mobility group box 1, a representative for damage-associated molecular patterns (DAMPs), were elevated during acute phase and continued to decrease during subacute phase. This unique course suggested the inflammatory process of KD involving innate immunity via DAMPs.

3.
Neuropediatrics ; 51(3): 211-214, 2020 06.
Article in English | MEDLINE | ID: mdl-31777044

ABSTRACT

Diazoxide is a peripheral vasodilator that has been used for intravenous treatment of hypertensive emergencies. However, it is currently used mainly for hyperinsulinemic hypoglycemia in lower dose orally, and its major side effects are edema and pulmonary hypertension. Herein, we report the first association between periventricular leukomalacia (PVL) and intractable hypotension due to diazoxide. A Japanese female premature infant showed hypoglycemia concomitant with hyperinsulinemia. She was diagnosed with congenital hyperinsulinism, and oral diazoxide was started. Six days after starting diazoxide, she suddenly showed peripheral coldness, oliguria, and severe hypotension. The hypotension was refractory to general vasopressor therapies and persisted even after the discontinuation of diazoxide. Cranial echography showed periventricular echodensities followed by cystic PVL. Low-dose vasopressin effectively treated the hypotension. This single case reminds us the serious adverse events of diazoxide that have been forgotten, especially in premature neonates.


Subject(s)
Congenital Hyperinsulinism/drug therapy , Diazoxide/adverse effects , Hypotension/chemically induced , Leukomalacia, Periventricular/chemically induced , Vasodilator Agents/adverse effects , Female , Humans , Infant, Newborn , Infant, Premature , Pregnancy , Pregnancy, Twin
5.
J Pediatr ; 213: 227-231.e1, 2019 10.
Article in English | MEDLINE | ID: mdl-31208780

ABSTRACT

Among children with Down syndrome, the frequency of motor rehabilitation intervention and the age at the start of this intervention are independently related to the age at onset of independent walking. Early motor rehabilitation, before age 6 months, may be effective in reducing motor delay in children with Down syndrome.


Subject(s)
Down Syndrome/rehabilitation , Early Medical Intervention/methods , Motor Skills Disorders/rehabilitation , Rehabilitation/methods , Birth Weight , Case-Control Studies , Child, Preschool , Developmental Disabilities/rehabilitation , Female , Humans , Infant , Infant, Newborn , Infant, Premature , Japan , Male , Motor Skills , Program Evaluation , Retrospective Studies , Walking
6.
Yonsei Med J ; 60(3): 312-314, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30799595

ABSTRACT

We report the first case demonstrating an association between Kawasaki disease (KD) and erythema nodosum (EN). A 3-year-old girl presented with EN as an initial manifestation of KD. At the initial visit, she showed high fever of 40°C, injection of the oropharynx, cervical lymphadenopathy, and red-purple cutaneous nodules, particularly on the lower limbs. She complained of severe pain in the neck and cutaneous lesions. Initially, the development of EN was attributed to Salmonella spp infection, which was detected in stool culture. However, the patient did not respond to high-dose ampicillin/sulbactam to which the Salmonella spp is sensitive. Echocardiography performed as screening for fever of unknown origin revealed medium-sized aneurysms of the left anterior descending artery. EN masked the diagnosis of KD, and the patient developed a coronary artery lesion. KD should be considered in the differential diagnosis of refractory EN in pediatric patients.


Subject(s)
Erythema Nodosum/diagnosis , Mucocutaneous Lymph Node Syndrome/diagnosis , Skin Neoplasms/diagnosis , Child, Preschool , Diagnosis, Differential , Erythema Nodosum/diagnostic imaging , Female , Humans , Mucocutaneous Lymph Node Syndrome/diagnostic imaging , Pregnancy , Skin Neoplasms/diagnostic imaging
7.
AJP Rep ; 5(2): e089-92, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26495160

ABSTRACT

Background Herpes simplex virus (HSV) infection carries one of the poorest outcomes of neonatal liver failure (NLF). Neonates with disseminated HSV infection can develop hemophagocytic lymphohistiocytosis (HLH), and occasionally need orthotopic liver transplantation. Early interventions may be critical for the cure of NLF. Case Report We describe herewith a 6-day-old neonate with fulminant hepatic failure due to disseminated HSV-1 infection, who successfully responded to high-dose corticosteroid therapy 72 hours after the onset of disease. Preceding acyclovir, gamma globulin, and exchange blood transfusion therapies failed to control the disease. Methylprednisolone pulse therapy led to a drastic improvement of liver function and cytokine storms, and prevented the disease progression to HLH. Sustained levels of plasma and cerebrospinal fluid HSV DNA declined after prolonged acyclovir therapy. Bilateral lesions of the periventricular white matter areas, assessed by magnetic resonance imaging, disappeared at 3 months of age. The infant showed normal growth and development at 4 years of age. Conclusion Early anti-hypercytokinemia therapy using corticosteroid, and prolonged antiviral therapy might only provide the transplantation-free cure of NLF with HSV dissemination.

8.
Brain Dev ; 36(8): 670-5, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24268747

ABSTRACT

BACKGROUND: Tau protein is a microtubule-associated protein that is present in axons. Elevated tau protein levels in cerebrospinal fluid or serum are associated with several central nervous system diseases and can indicate neuronal injury. OBJECTIVE: In the present study, we measured and then compared serum tau protein levels between infants with neonatal asphyxia and control subjects. We examined these data to investigate the correlation between serum tau protein levels and neurological outcomes after neonatal asphyxia. PATIENTS AND METHODS: Serum tau protein levels were determined by an enzyme-linked immunosorbent assay in 19 neonates with neonatal asphyxia. Of these 19 neonates, 3 had severe spastic tetraplegia, and 1 had west syndrome. A group of 19 unaffected neonates was included in the study as a control group. RESULTS: Serum tau protein levels on postnatal day 3 were significantly higher in the poor outcome group than those in the good outcome (p=0.010) and control groups (p=0.006). On postnatal day 7, serum tau protein levels again were significantly higher in the poor outcome group than those in the good outcome (p=0.007) and control groups (p=0.006). CONCLUSIONS: The present findings indicate serum tau protein levels measured on postnatal days 3 and 7 can predict neurological prognosis following neonatal asphyxia.


Subject(s)
Asphyxia Neonatorum/diagnosis , tau Proteins/blood , Asphyxia Neonatorum/blood , Biomarkers/blood , Female , Gestational Age , Humans , Infant, Newborn , Male , Prognosis
9.
J Neurol Sci ; 321(1-2): 39-42, 2012 Oct 15.
Article in English | MEDLINE | ID: mdl-22863291

ABSTRACT

OBJECTIVE: Neurofilament (NF) is a major cytoskeletal protein of neurons. Elevation of serum NF concentration suggests neuronal injury, especially damage to axons. We assessed neuronal damage in febrile seizure (FS) by using NF. METHODS: We used enzyme-linked immunosorbent assay to measure serum levels of the phosphorylated form of NF-heavy chain (pNF-H) in 42 children with FS and 28 controls. RESULTS: Serum pNF-H levels in children with prolonged febrile seizure (PFS) (n=29) were significantly higher than those in the controls (p<0.001). There were no significant differences in serum pNF-H levels between children with simple febrile seizure (n=9) and the controls. There was a significant correlation between seizure duration and serum pNF-H levels during the first week in children with FS (p=0.022, r=0.37). CONCLUSION: Our results suggest that PFS could lead to some degree of neuronal damage even in the absence of abnormal clinical neurological findings during the short-term follow up period.


Subject(s)
Neurofilament Proteins/blood , Seizures, Febrile/blood , Child , Child, Preschool , Enzyme-Linked Immunosorbent Assay , Female , Humans , Infant , Male
10.
J Neurol ; 256(11): 1846-50, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19672673

ABSTRACT

The pathogenesis of non-herpetic acute limbic encephalitis (NHALE) has been not clear. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase 1 (TIMP-1) play important roles in the function of the blood-brain barrier. We measured the serum concentrations of MMP-9 and TIMP-1 by using enzyme-linked immunosorbent assay (ELISA) in 23 patients with NHALE in the acute and convalescent stages. Serum MMP-9 concentrations and ratios of serum MMP-9/TIMP-1 were significantly higher (1) in patients with NHALE in acute and convalescent stages than in control patients (all P < 0.001); (2) in patients with NHALE at the acute stage compared with those at the convalescent stage (P = 0.004, and P = 0.014, respectively). In contrast, serum TIMP-1 concentrations were significantly lower in patients with NHALE in the acute and convalescent stages than in control patients (both P < 0.001) but did not differ in patients with NHALE in the acute and convalescent stages. Our preliminary study suggests that the prolonged imbalance of MMP-9 and TIMP-1 is associated with the pathogenesis of NHALE.


Subject(s)
Encephalitis/blood , Encephalitis/pathology , Limbic System/pathology , Matrix Metalloproteinase 9/blood , Tissue Inhibitor of Metalloproteinase-1/blood , Adolescent , Adult , Aged , Autoantibodies/blood , Autoantibodies/cerebrospinal fluid , Encephalitis/physiopathology , Enzyme-Linked Immunosorbent Assay/methods , Female , Humans , Limbic System/virology , Magnetic Resonance Imaging , Male , Matrix Metalloproteinase 9/genetics , Middle Aged , Receptors, N-Methyl-D-Aspartate/immunology , Statistics, Nonparametric , Tissue Inhibitor of Metalloproteinase-1/genetics , Young Adult
11.
Pediatr Pulmonol ; 44(3): 267-72, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19205055

ABSTRACT

We investigated matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase 1 (TIMP-1) levels in the cord blood of 29 premature infants who were <30 weeks gestation. One, 8, and 14 infants developed severe, moderate and mild bronchopulmonary dysplasia (BPD), respectively, and 6 did not. MMP-9 and TIMP-1 levels in the cord blood were determined by ELISA. MMP-9/TIMP-1 ratios in the cord blood of infants who developed severe or moderate BPD (n = 9) were significantly higher than those who developed mild BPD or did not develop BPD (n = 20; P = 0.015). Multivariate linear regressions demonstrated that MMP-9 levels and MMP-9/TIMP-1 ratios in the cord blood of the premature infants correlated with the oxygen supplementation period (r = 0.58, P = 0.003 and r = 0.41, P = 0.030, respectively). The MMP-9 levels and MMP-9/TIMP-1 ratios correlated with the severity of maternal chorioamnionitis (both trend P = 0.006). The MMP-9 levels and MMP-9/TIMP-1 ratios in the cord blood may be related to the pathogenesis and severity of BPD and maternal chorioamnionitis.


Subject(s)
Bronchopulmonary Dysplasia/blood , Fetal Blood/metabolism , Infant, Premature, Diseases/blood , Matrix Metalloproteinase 9/blood , Tissue Inhibitor of Metalloproteinase-1/blood , Bronchopulmonary Dysplasia/diagnosis , Chorioamnionitis/blood , Female , Gestational Age , Humans , Infant, Extremely Low Birth Weight , Infant, Newborn , Infant, Premature , Infant, Premature, Diseases/diagnosis , Male , Pregnancy , Retrospective Studies , Severity of Illness Index
12.
J Neurol Sci ; 280(1-2): 59-61, 2009 May 15.
Article in English | MEDLINE | ID: mdl-19237165

ABSTRACT

Neurofilament (NF) is one of the major cytoskeleton proteins of neurons. We investigated the concentrations of the heavy subunit of NF (NF-H) in cerebrospinal fluid (CSF) as biomarkers of neuronal injury in bacterial meningitis. Concentrations of NF-H in CSF of 26 children with bacterial meningitis and in 16 control subjects were measured by ELISA. The CSF NF-H levels were elevated in 22 of the 26 children (85%) with bacterial meningitis. The peak CSF NF-H level occurred at a median period of 10.5 days after onset of illness (range, 1 to 35 days). The peak CSF NF-H levels of the patients with neurological sequelae (n=4) were significantly higher than those without sequelae (n=22) (7.06 vs. 2.46 ng/mL as median, p=0.048). There was no significant difference in CSF NF-H levels between patients with and without severe neurological sequelae up to day 14 of illness, but the CSF NF-H levels in patients with sequelae were significantly higher than in those without sequelae after day 14 of illness (2.04 vs. 1.19 ng/mL as median, p=0.024). We suggest that neuronal injury occurs in bacterial meningitis regardless of the presence or absence of neurological sequelae.


Subject(s)
Meningitis, Bacterial/cerebrospinal fluid , Neurofilament Proteins/cerebrospinal fluid , Child, Preschool , Enzyme-Linked Immunosorbent Assay , Female , Hearing Loss, Sensorineural/cerebrospinal fluid , Hearing Loss, Sensorineural/complications , Humans , Infant , Infant, Newborn , Intellectual Disability/cerebrospinal fluid , Intellectual Disability/complications , Male , Meningitis, Bacterial/complications , Meningitis, Escherichia coli/cerebrospinal fluid , Meningitis, Escherichia coli/complications , Meningitis, Haemophilus/cerebrospinal fluid , Meningitis, Haemophilus/complications , Meningitis, Pneumococcal/cerebrospinal fluid , Meningitis, Pneumococcal/complications , Methicillin-Resistant Staphylococcus aureus , Paresis/cerebrospinal fluid , Paresis/complications , Time Factors
13.
Brain Dev ; 31(8): 588-93, 2009 Sep.
Article in English | MEDLINE | ID: mdl-18849127

ABSTRACT

Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) play important roles in the function of the blood-brain-barrier (BBB). We investigated the roles of MMP-9 and TIMP-1 in the pathogenesis of hypoxic-ischemic encephalopathy following perinatal asphyxia. Serum concentrations of MMP-9 and TIMP-1 were determined by ELISA in 12 neonates with perinatal asphyxia and 15 controls on the birth day and the next day. Serum MMP-9 concentrations in asphyxiated neonates with neurological sequelae (n=5) were significantly higher than concentration in asphyxiated neonates without sequelae (n=7) and controls on birth day (p=0.003 and p<0.001, respectively). The ratios of serum MMP-9/TIMP-1 on birth day in asphyxiated neonates with neurological sequelae were significantly higher than those in asphyxiated neonates without sequelae (p=0.048). There were no significant differences in the serum MMP-9 concentrations or the ratios of MMP-9/TIMP-1 between asphyxiated neonates with and without neurological sequelae on the day after birth. Our preliminary study suggests that serum MMP-9 levels on birth day are important for predicting neurological prognosis of neonates with asphyxia.


Subject(s)
Asphyxia Neonatorum/blood , Matrix Metalloproteinase 9/blood , Tissue Inhibitor of Metalloproteinase-1/blood , Enzyme-Linked Immunosorbent Assay , Female , Humans , Infant, Newborn , Male , Predictive Value of Tests , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL
...